カテゴリー： Market Monitor Global, 世界, 部品/材料

テルミサルタンAPIの世界市場見通し2023年-2029年

◆英語タイトル：Telmisartan API Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY2192 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：111 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Telmisartan API Market 調査レポートは次の情報を含め、グローバルにおけるのテルミサルタンAPI市場規模と予測を収録しています。・世界のテルミサルタンAPI市場：売上、2018年-2023年、2024年-2029年
・世界のテルミサルタンAPI市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のテルミサルタンAPI市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度≧99%」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

テルミサルタンAPIのグローバル主要企業は、Rundu Pharma、 Jiangxi Synergy Pharmaceutical、 Apeloa Pharmaceutical、 Tianyu Pharmaceutical、 Zhejiang Kinglyuan Pharmaceutical、 Weightech (Hunan) Pharmaceutical、 Liu He Pharmaceutical、 Verdant Life Sciences、 SMILAX、 Cipla、 Atom Pharma、 Aalidhra Pharmachem、 Dr. Reddy's Laboratories、 InterQuim、 RL Fine Chemなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、テルミサルタンAPIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のテルミサルタンAPI市場：タイプ別、2018年-2023年、2024年-2029年
世界のテルミサルタンAPI市場：タイプ別市場シェア、2022年
・純度≧99%、純度≧99.5%

世界のテルミサルタンAPI市場：用途別、2018年-2023年、2024年-2029年
世界のテルミサルタンAPI市場：用途別市場シェア、2022年
・錠剤、カプセル、その他

世界のテルミサルタンAPI市場：地域・国別、2018年-2023年、2024年-2029年
世界のテルミサルタンAPI市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるテルミサルタンAPIのグローバル売上、2018年-2023年
・主要企業におけるテルミサルタンAPIのグローバル売上シェア、2022年
・主要企業におけるテルミサルタンAPIのグローバル販売量、2018年-2023年
・主要企業におけるテルミサルタンAPIのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Rundu Pharma、 Jiangxi Synergy Pharmaceutical、 Apeloa Pharmaceutical、 Tianyu Pharmaceutical、 Zhejiang Kinglyuan Pharmaceutical、 Weightech (Hunan) Pharmaceutical、 Liu He Pharmaceutical、 Verdant Life Sciences、 SMILAX、 Cipla、 Atom Pharma、 Aalidhra Pharmachem、 Dr. Reddy's Laboratories、 InterQuim、 RL Fine Chem

*************************************************************

・調査・分析レポートの概要
テルミサルタンAPI市場の定義
市場セグメント
世界のテルミサルタンAPI市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のテルミサルタンAPI市場規模
世界のテルミサルタンAPI市場規模：2022年 VS 2029年
世界のテルミサルタンAPI市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのテルミサルタンAPIの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のテルミサルタンAPI製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：純度≧99%、純度≧99.5%
テルミサルタンAPIのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：錠剤、カプセル、その他
テルミサルタンAPIの用途別グローバル売上・予測

・地域別市場分析
地域別テルミサルタンAPI市場規模 2022年と2029年
地域別テルミサルタンAPI売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Rundu Pharma、 Jiangxi Synergy Pharmaceutical、 Apeloa Pharmaceutical、 Tianyu Pharmaceutical、 Zhejiang Kinglyuan Pharmaceutical、 Weightech (Hunan) Pharmaceutical、 Liu He Pharmaceutical、 Verdant Life Sciences、 SMILAX、 Cipla、 Atom Pharma、 Aalidhra Pharmachem、 Dr. Reddy's Laboratories、 InterQuim、 RL Fine Chem
...

This report aims to provide a comprehensive presentation of the global market for Telmisartan API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telmisartan API. This report contains market size and forecasts of Telmisartan API in global, including the following market information:
Global Telmisartan API Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Telmisartan API Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Telmisartan API companies in 2022 (%)
The global Telmisartan API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity ≥ 99% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Telmisartan API include Rundu Pharma, Jiangxi Synergy Pharmaceutical, Apeloa Pharmaceutical, Tianyu Pharmaceutical, Zhejiang Kinglyuan Pharmaceutical, Weightech (Hunan) Pharmaceutical, Liu He Pharmaceutical, Verdant Life Sciences and SMILAX, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Telmisartan API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Telmisartan API Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Telmisartan API Market Segment Percentages, by Type, 2022 (%)
Purity ≥ 99%
Purity ≥ 99.5%
Global Telmisartan API Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Telmisartan API Market Segment Percentages, by Application, 2022 (%)
Tablet
Capsule
Other
Global Telmisartan API Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Telmisartan API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Telmisartan API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Telmisartan API revenues share in global market, 2022 (%)
Key companies Telmisartan API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Telmisartan API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Rundu Pharma
Jiangxi Synergy Pharmaceutical
Apeloa Pharmaceutical
Tianyu Pharmaceutical
Zhejiang Kinglyuan Pharmaceutical
Weightech (Hunan) Pharmaceutical
Liu He Pharmaceutical
Verdant Life Sciences
SMILAX
Cipla
Atom Pharma
Aalidhra Pharmachem
Dr. Reddy’s Laboratories
InterQuim
RL Fine Chem
Outline of Major Chapters:
Chapter 1: Introduces the definition of Telmisartan API, market overview.
Chapter 2: Global Telmisartan API market size in revenue and volume.
Chapter 3: Detailed analysis of Telmisartan API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Telmisartan API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Telmisartan API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Telmisartan API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Telmisartan API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Telmisartan API Overall Market Size
2.1 Global Telmisartan API Market Size: 2022 VS 2029
2.2 Global Telmisartan API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Telmisartan API Sales: 2018-2029
3 Company Landscape
3.1 Top Telmisartan API Players in Global Market
3.2 Top Global Telmisartan API Companies Ranked by Revenue
3.3 Global Telmisartan API Revenue by Companies
3.4 Global Telmisartan API Sales by Companies
3.5 Global Telmisartan API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Telmisartan API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Telmisartan API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Telmisartan API Players in Global Market
3.8.1 List of Global Tier 1 Telmisartan API Companies
3.8.2 List of Global Tier 2 and Tier 3 Telmisartan API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Telmisartan API Market Size Markets, 2022 & 2029
4.1.2 Purity ≥ 99%
4.1.3 Purity ≥ 99.5%
4.2 By Type – Global Telmisartan API Revenue & Forecasts
4.2.1 By Type – Global Telmisartan API Revenue, 2018-2023
4.2.2 By Type – Global Telmisartan API Revenue, 2024-2029
4.2.3 By Type – Global Telmisartan API Revenue Market Share, 2018-2029
4.3 By Type – Global Telmisartan API Sales & Forecasts
4.3.1 By Type – Global Telmisartan API Sales, 2018-2023
4.3.2 By Type – Global Telmisartan API Sales, 2024-2029
4.3.3 By Type – Global Telmisartan API Sales Market Share, 2018-2029
4.4 By Type – Global Telmisartan API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Telmisartan API Market Size, 2022 & 2029
5.1.2 Tablet
5.1.3 Capsule
5.1.4 Other
5.2 By Application – Global Telmisartan API Revenue & Forecasts
5.2.1 By Application – Global Telmisartan API Revenue, 2018-2023
5.2.2 By Application – Global Telmisartan API Revenue, 2024-2029
5.2.3 By Application – Global Telmisartan API Revenue Market Share, 2018-2029
5.3 By Application – Global Telmisartan API Sales & Forecasts
5.3.1 By Application – Global Telmisartan API Sales, 2018-2023
5.3.2 By Application – Global Telmisartan API Sales, 2024-2029
5.3.3 By Application – Global Telmisartan API Sales Market Share, 2018-2029
5.4 By Application – Global Telmisartan API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Telmisartan API Market Size, 2022 & 2029
6.2 By Region – Global Telmisartan API Revenue & Forecasts
6.2.1 By Region – Global Telmisartan API Revenue, 2018-2023
6.2.2 By Region – Global Telmisartan API Revenue, 2024-2029
6.2.3 By Region – Global Telmisartan API Revenue Market Share, 2018-2029
6.3 By Region – Global Telmisartan API Sales & Forecasts
6.3.1 By Region – Global Telmisartan API Sales, 2018-2023
6.3.2 By Region – Global Telmisartan API Sales, 2024-2029
6.3.3 By Region – Global Telmisartan API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Telmisartan API Revenue, 2018-2029
6.4.2 By Country – North America Telmisartan API Sales, 2018-2029
6.4.3 US Telmisartan API Market Size, 2018-2029
6.4.4 Canada Telmisartan API Market Size, 2018-2029
6.4.5 Mexico Telmisartan API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Telmisartan API Revenue, 2018-2029
6.5.2 By Country – Europe Telmisartan API Sales, 2018-2029
6.5.3 Germany Telmisartan API Market Size, 2018-2029
6.5.4 France Telmisartan API Market Size, 2018-2029
6.5.5 U.K. Telmisartan API Market Size, 2018-2029
6.5.6 Italy Telmisartan API Market Size, 2018-2029
6.5.7 Russia Telmisartan API Market Size, 2018-2029
6.5.8 Nordic Countries Telmisartan API Market Size, 2018-2029
6.5.9 Benelux Telmisartan API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Telmisartan API Revenue, 2018-2029
6.6.2 By Region – Asia Telmisartan API Sales, 2018-2029
6.6.3 China Telmisartan API Market Size, 2018-2029
6.6.4 Japan Telmisartan API Market Size, 2018-2029
6.6.5 South Korea Telmisartan API Market Size, 2018-2029
6.6.6 Southeast Asia Telmisartan API Market Size, 2018-2029
6.6.7 India Telmisartan API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Telmisartan API Revenue, 2018-2029
6.7.2 By Country – South America Telmisartan API Sales, 2018-2029
6.7.3 Brazil Telmisartan API Market Size, 2018-2029
6.7.4 Argentina Telmisartan API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Telmisartan API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Telmisartan API Sales, 2018-2029
6.8.3 Turkey Telmisartan API Market Size, 2018-2029
6.8.4 Israel Telmisartan API Market Size, 2018-2029
6.8.5 Saudi Arabia Telmisartan API Market Size, 2018-2029
6.8.6 UAE Telmisartan API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Rundu Pharma
7.1.1 Rundu Pharma Company Summary
7.1.2 Rundu Pharma Business Overview
7.1.3 Rundu Pharma Telmisartan API Major Product Offerings
7.1.4 Rundu Pharma Telmisartan API Sales and Revenue in Global (2018-2023)
7.1.5 Rundu Pharma Key News & Latest Developments
7.2 Jiangxi Synergy Pharmaceutical
7.2.1 Jiangxi Synergy Pharmaceutical Company Summary
7.2.2 Jiangxi Synergy Pharmaceutical Business Overview
7.2.3 Jiangxi Synergy Pharmaceutical Telmisartan API Major Product Offerings
7.2.4 Jiangxi Synergy Pharmaceutical Telmisartan API Sales and Revenue in Global (2018-2023)
7.2.5 Jiangxi Synergy Pharmaceutical Key News & Latest Developments
7.3 Apeloa Pharmaceutical
7.3.1 Apeloa Pharmaceutical Company Summary
7.3.2 Apeloa Pharmaceutical Business Overview
7.3.3 Apeloa Pharmaceutical Telmisartan API Major Product Offerings
7.3.4 Apeloa Pharmaceutical Telmisartan API Sales and Revenue in Global (2018-2023)
7.3.5 Apeloa Pharmaceutical Key News & Latest Developments
7.4 Tianyu Pharmaceutical
7.4.1 Tianyu Pharmaceutical Company Summary
7.4.2 Tianyu Pharmaceutical Business Overview
7.4.3 Tianyu Pharmaceutical Telmisartan API Major Product Offerings
7.4.4 Tianyu Pharmaceutical Telmisartan API Sales and Revenue in Global (2018-2023)
7.4.5 Tianyu Pharmaceutical Key News & Latest Developments
7.5 Zhejiang Kinglyuan Pharmaceutical
7.5.1 Zhejiang Kinglyuan Pharmaceutical Company Summary
7.5.2 Zhejiang Kinglyuan Pharmaceutical Business Overview
7.5.3 Zhejiang Kinglyuan Pharmaceutical Telmisartan API Major Product Offerings
7.5.4 Zhejiang Kinglyuan Pharmaceutical Telmisartan API Sales and Revenue in Global (2018-2023)
7.5.5 Zhejiang Kinglyuan Pharmaceutical Key News & Latest Developments
7.6 Weightech (Hunan) Pharmaceutical
7.6.1 Weightech (Hunan) Pharmaceutical Company Summary
7.6.2 Weightech (Hunan) Pharmaceutical Business Overview
7.6.3 Weightech (Hunan) Pharmaceutical Telmisartan API Major Product Offerings
7.6.4 Weightech (Hunan) Pharmaceutical Telmisartan API Sales and Revenue in Global (2018-2023)
7.6.5 Weightech (Hunan) Pharmaceutical Key News & Latest Developments
7.7 Liu He Pharmaceutical
7.7.1 Liu He Pharmaceutical Company Summary
7.7.2 Liu He Pharmaceutical Business Overview
7.7.3 Liu He Pharmaceutical Telmisartan API Major Product Offerings
7.7.4 Liu He Pharmaceutical Telmisartan API Sales and Revenue in Global (2018-2023)
7.7.5 Liu He Pharmaceutical Key News & Latest Developments
7.8 Verdant Life Sciences
7.8.1 Verdant Life Sciences Company Summary
7.8.2 Verdant Life Sciences Business Overview
7.8.3 Verdant Life Sciences Telmisartan API Major Product Offerings
7.8.4 Verdant Life Sciences Telmisartan API Sales and Revenue in Global (2018-2023)
7.8.5 Verdant Life Sciences Key News & Latest Developments
7.9 SMILAX
7.9.1 SMILAX Company Summary
7.9.2 SMILAX Business Overview
7.9.3 SMILAX Telmisartan API Major Product Offerings
7.9.4 SMILAX Telmisartan API Sales and Revenue in Global (2018-2023)
7.9.5 SMILAX Key News & Latest Developments
7.10 Cipla
7.10.1 Cipla Company Summary
7.10.2 Cipla Business Overview
7.10.3 Cipla Telmisartan API Major Product Offerings
7.10.4 Cipla Telmisartan API Sales and Revenue in Global (2018-2023)
7.10.5 Cipla Key News & Latest Developments
7.11 Atom Pharma
7.11.1 Atom Pharma Company Summary
7.11.2 Atom Pharma Telmisartan API Business Overview
7.11.3 Atom Pharma Telmisartan API Major Product Offerings
7.11.4 Atom Pharma Telmisartan API Sales and Revenue in Global (2018-2023)
7.11.5 Atom Pharma Key News & Latest Developments
7.12 Aalidhra Pharmachem
7.12.1 Aalidhra Pharmachem Company Summary
7.12.2 Aalidhra Pharmachem Telmisartan API Business Overview
7.12.3 Aalidhra Pharmachem Telmisartan API Major Product Offerings
7.12.4 Aalidhra Pharmachem Telmisartan API Sales and Revenue in Global (2018-2023)
7.12.5 Aalidhra Pharmachem Key News & Latest Developments
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Company Summary
7.13.2 Dr. Reddy’s Laboratories Telmisartan API Business Overview
7.13.3 Dr. Reddy’s Laboratories Telmisartan API Major Product Offerings
7.13.4 Dr. Reddy’s Laboratories Telmisartan API Sales and Revenue in Global (2018-2023)
7.13.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.14 InterQuim
7.14.1 InterQuim Company Summary
7.14.2 InterQuim Business Overview
7.14.3 InterQuim Telmisartan API Major Product Offerings
7.14.4 InterQuim Telmisartan API Sales and Revenue in Global (2018-2023)
7.14.5 InterQuim Key News & Latest Developments
7.15 RL Fine Chem
7.15.1 RL Fine Chem Company Summary
7.15.2 RL Fine Chem Business Overview
7.15.3 RL Fine Chem Telmisartan API Major Product Offerings
7.15.4 RL Fine Chem Telmisartan API Sales and Revenue in Global (2018-2023)
7.15.5 RL Fine Chem Key News & Latest Developments
8 Global Telmisartan API Production Capacity, Analysis
8.1 Global Telmisartan API Production Capacity, 2018-2029
8.2 Telmisartan API Production Capacity of Key Manufacturers in Global Market
8.3 Global Telmisartan API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Telmisartan API Supply Chain Analysis
10.1 Telmisartan API Industry Value Chain
10.2 Telmisartan API Upstream Market
10.3 Telmisartan API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Telmisartan API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Telmisartan API in Global Market
Table 2. Top Telmisartan API Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Telmisartan API Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Telmisartan API Revenue Share by Companies, 2018-2023
Table 5. Global Telmisartan API Sales by Companies, (Tons), 2018-2023
Table 6. Global Telmisartan API Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Telmisartan API Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Telmisartan API Product Type
Table 9. List of Global Tier 1 Telmisartan API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Telmisartan API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Telmisartan API Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Telmisartan API Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Telmisartan API Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Telmisartan API Sales (Tons), 2018-2023
Table 15. By Type - Global Telmisartan API Sales (Tons), 2024-2029
Table 16. By Application – Global Telmisartan API Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Telmisartan API Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Telmisartan API Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Telmisartan API Sales (Tons), 2018-2023
Table 20. By Application - Global Telmisartan API Sales (Tons), 2024-2029
Table 21. By Region – Global Telmisartan API Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Telmisartan API Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Telmisartan API Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Telmisartan API Sales (Tons), 2018-2023
Table 25. By Region - Global Telmisartan API Sales (Tons), 2024-2029
Table 26. By Country - North America Telmisartan API Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Telmisartan API Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Telmisartan API Sales, (Tons), 2018-2023
Table 29. By Country - North America Telmisartan API Sales, (Tons), 2024-2029
Table 30. By Country - Europe Telmisartan API Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Telmisartan API Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Telmisartan API Sales, (Tons), 2018-2023
Table 33. By Country - Europe Telmisartan API Sales, (Tons), 2024-2029
Table 34. By Region - Asia Telmisartan API Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Telmisartan API Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Telmisartan API Sales, (Tons), 2018-2023
Table 37. By Region - Asia Telmisartan API Sales, (Tons), 2024-2029
Table 38. By Country - South America Telmisartan API Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Telmisartan API Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Telmisartan API Sales, (Tons), 2018-2023
Table 41. By Country - South America Telmisartan API Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Telmisartan API Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Telmisartan API Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Telmisartan API Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Telmisartan API Sales, (Tons), 2024-2029
Table 46. Rundu Pharma Company Summary
Table 47. Rundu Pharma Telmisartan API Product Offerings
Table 48. Rundu Pharma Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Rundu Pharma Key News & Latest Developments
Table 50. Jiangxi Synergy Pharmaceutical Company Summary
Table 51. Jiangxi Synergy Pharmaceutical Telmisartan API Product Offerings
Table 52. Jiangxi Synergy Pharmaceutical Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Jiangxi Synergy Pharmaceutical Key News & Latest Developments
Table 54. Apeloa Pharmaceutical Company Summary
Table 55. Apeloa Pharmaceutical Telmisartan API Product Offerings
Table 56. Apeloa Pharmaceutical Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Apeloa Pharmaceutical Key News & Latest Developments
Table 58. Tianyu Pharmaceutical Company Summary
Table 59. Tianyu Pharmaceutical Telmisartan API Product Offerings
Table 60. Tianyu Pharmaceutical Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Tianyu Pharmaceutical Key News & Latest Developments
Table 62. Zhejiang Kinglyuan Pharmaceutical Company Summary
Table 63. Zhejiang Kinglyuan Pharmaceutical Telmisartan API Product Offerings
Table 64. Zhejiang Kinglyuan Pharmaceutical Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. Zhejiang Kinglyuan Pharmaceutical Key News & Latest Developments
Table 66. Weightech (Hunan) Pharmaceutical Company Summary
Table 67. Weightech (Hunan) Pharmaceutical Telmisartan API Product Offerings
Table 68. Weightech (Hunan) Pharmaceutical Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Weightech (Hunan) Pharmaceutical Key News & Latest Developments
Table 70. Liu He Pharmaceutical Company Summary
Table 71. Liu He Pharmaceutical Telmisartan API Product Offerings
Table 72. Liu He Pharmaceutical Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Liu He Pharmaceutical Key News & Latest Developments
Table 74. Verdant Life Sciences Company Summary
Table 75. Verdant Life Sciences Telmisartan API Product Offerings
Table 76. Verdant Life Sciences Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Verdant Life Sciences Key News & Latest Developments
Table 78. SMILAX Company Summary
Table 79. SMILAX Telmisartan API Product Offerings
Table 80. SMILAX Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. SMILAX Key News & Latest Developments
Table 82. Cipla Company Summary
Table 83. Cipla Telmisartan API Product Offerings
Table 84. Cipla Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. Cipla Key News & Latest Developments
Table 86. Atom Pharma Company Summary
Table 87. Atom Pharma Telmisartan API Product Offerings
Table 88. Atom Pharma Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. Atom Pharma Key News & Latest Developments
Table 90. Aalidhra Pharmachem Company Summary
Table 91. Aalidhra Pharmachem Telmisartan API Product Offerings
Table 92. Aalidhra Pharmachem Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 93. Aalidhra Pharmachem Key News & Latest Developments
Table 94. Dr. Reddy's Laboratories Company Summary
Table 95. Dr. Reddy's Laboratories Telmisartan API Product Offerings
Table 96. Dr. Reddy's Laboratories Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 97. Dr. Reddy's Laboratories Key News & Latest Developments
Table 98. InterQuim Company Summary
Table 99. InterQuim Telmisartan API Product Offerings
Table 100. InterQuim Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 101. InterQuim Key News & Latest Developments
Table 102. RL Fine Chem Company Summary
Table 103. RL Fine Chem Telmisartan API Product Offerings
Table 104. RL Fine Chem Telmisartan API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 105. RL Fine Chem Key News & Latest Developments
Table 106. Telmisartan API Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 107. Global Telmisartan API Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Telmisartan API Production by Region, 2018-2023 (Tons)
Table 109. Global Telmisartan API Production by Region, 2024-2029 (Tons)
Table 110. Telmisartan API Market Opportunities & Trends in Global Market
Table 111. Telmisartan API Market Drivers in Global Market
Table 112. Telmisartan API Market Restraints in Global Market
Table 113. Telmisartan API Raw Materials
Table 114. Telmisartan API Raw Materials Suppliers in Global Market
Table 115. Typical Telmisartan API Downstream
Table 116. Telmisartan API Downstream Clients in Global Market
Table 117. Telmisartan API Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Telmisartan API Segment by Type in 2022
Figure 2. Telmisartan API Segment by Application in 2022
Figure 3. Global Telmisartan API Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Telmisartan API Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Telmisartan API Revenue, 2018-2029 (US$, Mn)
Figure 7. Telmisartan API Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Telmisartan API Revenue in 2022
Figure 9. By Type - Global Telmisartan API Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Telmisartan API Revenue Market Share, 2018-2029
Figure 11. By Type - Global Telmisartan API Sales Market Share, 2018-2029
Figure 12. By Type - Global Telmisartan API Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Telmisartan API Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Telmisartan API Revenue Market Share, 2018-2029
Figure 15. By Application - Global Telmisartan API Sales Market Share, 2018-2029
Figure 16. By Application - Global Telmisartan API Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Telmisartan API Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Telmisartan API Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Telmisartan API Revenue Market Share, 2018-2029
Figure 20. By Region - Global Telmisartan API Sales Market Share, 2018-2029
Figure 21. By Country - North America Telmisartan API Revenue Market Share, 2018-2029
Figure 22. By Country - North America Telmisartan API Sales Market Share, 2018-2029
Figure 23. US Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Telmisartan API Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Telmisartan API Sales Market Share, 2018-2029
Figure 28. Germany Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 29. France Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Telmisartan API Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Telmisartan API Sales Market Share, 2018-2029
Figure 37. China Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 41. India Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Telmisartan API Revenue Market Share, 2018-2029
Figure 43. By Country - South America Telmisartan API Sales Market Share, 2018-2029
Figure 44. Brazil Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Telmisartan API Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Telmisartan API Sales Market Share, 2018-2029
Figure 48. Turkey Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Telmisartan API Revenue, (US$, Mn), 2018-2029
Figure 52. Global Telmisartan API Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Telmisartan API by Region, 2022 VS 2029
Figure 54. Telmisartan API Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ テルミサルタンAPIの世界市場見通し2023年-2029年(Telmisartan API Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

テルミサルタンAPIの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp